A Novel Multiplex PCR Based Detection Assay Using Saliva or Nasopharyngeal Samples for SARS-Cov-2, Influenza A and B: Clinical Validation and Utility for Mass Surveillance.

Research output: Other contribution

Original languageEnglish (US)
DOIs
StatePublished - Mar 2021

Cite this